Mylan N.V. rejected Teva Pharmaceuticals' $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company. … Click to Continue »
Living articles about food home & travel from in Kansas City, MO | KansasCity.com, Kansas City Star: Living
Mon, 04/27/2015 - 7:49am
Mylan N.V. rejected Teva Pharmaceuticals' $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company. … Click to Continue »